Tissue glucocorticoid metabolism in adrenal insufficiency: a prospective study of dual-release hydrocortisone therapy.
Rosemary A DineenJulie Martin-GraceKhalid Mohamed Saeed AhmedAngela E TaylorFozia ShaheenLina SchifferLorna C GilliganGareth G LaveryIsolda FrizelleAnjuli GunnessAoife GarrahyAnne Marie HannonPaal MethlieSverre Husebye EysteinPaul M StewartJeremy W TomlinsonJames M HawleyBrian G KeevilMichael W O'ReillyDiarmuid SmithJohn McDermottMarie-Louise HealyAmar AghaAgnieszka PazderskaJames GibneyLucy-Ann BehanChris J ThompsonWiebeke ArltMark SherlockPublished in: The Journal of clinical endocrinology and metabolism (2023)
Using comprehensive in-vivo techniques, we have demonstrated abnormalities in corticosteroid metabolism in patients with primary and secondary AI receiving IR-HC. This dysregulation of pre-receptor glucocorticoid metabolism results in enhanced glucocorticoid activation in adipose tissue, which was ameliorated by treatment with DR-HC.